TARRYTOWN, N.Y., Oct. 6, 2020 /PRNewswire/ -- Regeneron
Pharmaceuticals, Inc. (NASDAQ: REGN) today
announced that it will report its third quarter 2020 financial and
operating results on Thursday, November 5,
2020, before the U.S. financial markets open. The
Company will host a conference call and simultaneous webcast at
8:30 AM Eastern Time that day.
Conference Call Information
To access this call, dial
(888) 660-6127 (U.S.) or (973) 890-8355 (International), conference
ID 1535889. A link to the webcast may be accessed from the
'Investors and Media' page of Regeneron's website at
http://investor.regeneron.com/events.cfm. A replay of the
conference call and webcast will be archived on the Company's
website for at least 30 days.
About Regeneron
Regeneron (NASDAQ: REGN)
is a leading biotechnology company that invents life-transforming
medicines for people with serious diseases. Founded and led for
over 30 years by physician-scientists, our unique ability to
repeatedly and consistently translate science into medicine has led
to seven FDA-approved treatments and numerous product candidates in
development, all of which were homegrown in our laboratories. Our
medicines and pipeline are designed to help patients with eye
diseases, allergic and inflammatory diseases, cancer,
cardiovascular and metabolic diseases, pain, infectious diseases
and rare diseases.
Regeneron is accelerating and improving the traditional drug
development process through our proprietary
VelociSuite® technologies, such as
VelocImmune® which uses unique
genetically-humanized mice to produce optimized fully-human
antibodies and bispecific antibodies, and through ambitious
research initiatives such as the Regeneron Genetics Center, which
is conducting one of the largest genetics sequencing efforts in the
world.
For additional information about the company, please
visit www.regeneron.com or follow @Regeneron on
Twitter.
Contact Information:
Investor Relations
Justin Holko
914.847.7786
justin.holko@regeneron.com
Corporate Communications
Hala Mirza
914.847.3422
hala.mirza@regeneron.com
View original
content:http://www.prnewswire.com/news-releases/regeneron-to-report-third-quarter-2020-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-5-2020-301147030.html
SOURCE Regeneron Pharmaceuticals, Inc.